Biotech, Ballistics, Blockchain & Battlespace Tech Dominate Today’s Market Narrative
DENVER, Colo., Oct 22, 2025 (247marketnews.com)- Forget steel, the next revolution in ballistic protection might come from a worm. Kraig Biocraft Laboratories (OTCQB:KBLB) has quietly cracked a problem that eluded researchers for decades: how to scale spider silk production.
- Spider silk has long been hailed as stronger than Kevlar on a per-weight basis.
- But spiders can’t be farmed. KBLB’s solution? Genetically engineered silkworms that spin authentic spider silk.
- The implications? Huge, from bulletproof vests and combat uniforms to blast-resistant fabrics and lightweight armor inserts.
In a world of increasing defense budgets and calls for more mobile, breathable gear, spider silk may finally become a strategic material and Kraig Labs has a head start.
Applied DNA Sciences (NASDAQ:BNBX) is making headlines with a bold pivot into digital assets:
- Closed a PIPE financing for up to $58 million, led by DeFi/TradFi investors.
- Launched a BNB-focused digital asset treasury, acquiring over 10,600 BNB tokens and purchasing an additional 4,908 BNB (~$5.3M).
- Initial OBNB trust holdings are valued at $11.7 million.
CEO Clay Shorrock says the company is aligning resources with “strategic priorities,” streamlining ops for $2.9M in annual cost savings.
CIO Patrick Horsman added that he sees BNB as the next institutional-grade blockchain.
Beneficient (NASDAQ:BENF) just got a much-needed capital structure shake-up.
- Chairman Thomas O. Hicks and Interim CEO James G. Silk voluntarily converted $52.6M in preferred equity into common shares.
- The move boosts shareholder equity and aims to meet Nasdaq’s minimum listing requirements.
- Importantly, the newly issued shares are locked up until 2028 and subject to forfeiture of any value gains during the period.
“This conversion reinforces the confidence of our leadership,” said Hicks and Silk.
BENF hopes this signals strength to investors and simplifies its structure amid compliance pressure.
NUBURU (NYSE:BURU) is taking blue-laser tech airborne through a joint venture with Maddox Defense and Nuburu Defense LLC.
Key details:
- JV will develop next-gen drones for NATO and allied military customers.
- Targets include a $7–$10.3B annual NATO UAV market.
- Commercial drone revenue is expected to reach $100M annually by 2028.
The drones will use:
- Blue-laser targeting systems
- Modular 3D printing pods for field assembly
- The Orbit operational resilience system, recently acquired by NUBURU
JV formation is expected by December 15, 2025, with operations based in Europe under Italian law, compliant with U.S. export controls.
With growing geopolitical demand for agile, intelligent defense systems, BURU is positioning itself for global relevance in the defense-tech race.
Volume Watch: AiRWA (NASDAQ:YYAI) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Some of the sub quarter names making serious noise on the tape this morning include:
- AiRWA has already surpassed 1 billion shares traded, riding the wave of speculative microcap momentum.
- Adaptimmune Therapeutics is on pace to break half a billion as well, with traders watching closely to see if it matches AiRWA’s historic surge.
Both names are drawing in high-frequency retail flow, though fundamental catalysts remain unclear. Expect continued volatility.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
CONTACT:
24/7 Market News
Editor@247marketnews.com